International Cannabinoid Derived Pharmaceuticals Summit
Evvnt Promotion / evvnt
Archive
10.12.2018 - 12.12.2018 Hyatt Regency Boston, 1 Avenue de Lafayette, 02111 Boston, USA
Time: 8:00 am - 6:00 pm
Conference themes
With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.
With 17+ hours of content, we will be tackling the key issues from the benchside to commercialization. By considering a range of therapeutic areas, the conference is designed exclusively for the Cannabinoid drug developer. Our speakers will discuss complex Cannabinoid pharmacology, formulations, clinical trials, patient education and commercial challenges.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Notes
Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamas Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, and others
Speakers: Chris Bunka, Chairman of the Board and Chief Executive Officer, Lexaria Biosciences, Tamas Biro, Professor, Research Center for Molecular Medicine Departments of Immunology and Physiology, University of Debrecen, and others
Enquiries and Registration:
https://go.evvnt.com/267417-0?pid=4832
Ms. Kaltrina Kastrati
Pharmacology and Toxicology
Languages
English
English
Congress fees
Conference Only: GBP 1999.0, Conference + 2 Workshops: GBP 2897.0
Conference Only: GBP 1999.0, Conference + 2 Workshops: GBP 2897.0
Organizer contact info
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International promotes access to education and training for all regardless of social, geographic and national borders."
